XL Kits

text

October 9, 2025

FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Designed for Optimal CD137 Engagement Resulting in Potent Conditional T-Cell Activity

Authors Matthew A. Lakins1, Christel Séguy Veyssier2, Jose Munoz-Olaya1, Emma Goodman1, Robert Hughes1,...

Author : Payal

Category : Publications, XL Kits

text

August 1, 2024

Pharmaceutical Composition for Treating Brain Diseases Comprising Antibody Specifically Binding to ASM Protein as Active Ingredient

Inventors Seung Beom Hong, Jae Sung BAE, Hee Kyung Jin Assignees ISU ABXIS Co Ltd, Industry Academic...

Author : Payal

Category : Patents, Epitope Mapping

text

December 27, 2022

Time-Resolved Imaging of High Mass Proteins and Metastable Fragments Using Matrix-Assisted Laser Desorption/Ionization, Axial Time-of-Flight Mass Spectrometry, and TPX3CAM

Authors Anjusha Mathew1, Joel D. Keelor2, Gert B. Eijkel1, Ian G. M. Anthony1, Jingming Long2, Jord...

Author : dev_team

Category : Publications, HM5

text

March 24, 2022

Bispecific Binding Molecules Against Vegf and Ang2

Inventors Chiungkuang Chen, Aishwarya Kundu, Sreenivasu Mudumba, Masaaki Kageyama, Akira Nonoyama, Atsushi...

Author : dev_team

Category : Patents, High-Mass MS

text

March 6, 2021

Humanized, Mouse Or Chimeric Anti-CD47 Monoclonal Antibodies

Inventors Nicola Beltraminelli, Marie CHÂLONS-COTTAVOZ, Stéphanie FALLOT, Pierre Garrone, Mehdi Lahmar,...

Author : dev_team

Category : Patents, HM5

text

March 3, 2021

Hallmarks of Alpha and Betacoronavirus Non-Structural Protein 7+8 Complexes

Authors Boris Krichel1, Ganesh Bylapudi2, Christina Schmidt3, Clement Blanchet4, Robin Schubert3, Lea...

Author : dev_team

Category : Publications, High-Mass MS

text

December 29, 2020

An IgG-Based Bispecific Antibody for Improved Dual Targeting in PSMA-Positive Cancer

Authors Latifa Zekri1,2,3, Fabian Vogt1, Lukas Osburg1, Stefanie Müller2,3, Joseph Kauer1,2,3, Timo Manz1,...

Author : dev_team

Category : Publications, Epitope Mapping

text

December 1, 2020

The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism

Authors Thomas C. Buckles1, Yohei Ohashi2, Shirley Tremel2, Stephen H. McLaughlin2, Els Pardon3,4, Jan...

Author : dev_team

Category : Publications, XL Kits

text

December 1, 2020

Anti-SIRPα Antibodies

Inventors Hans Van Eenennaam, Andrea Van Elsas, Erik VOETS, Paul VINK, David Lutje Hulsik Assignees Sairopa...

Author : Payal

Category : Patents, High-Mass MS

XL Kits

FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Designed for Optimal CD137 Engagement Resulting in Potent Conditional T-Cell Activity

Pharmaceutical Composition for Treating Brain Diseases Comprising Antibody Specifically Binding to ASM Protein as Active Ingredient

Time-Resolved Imaging of High Mass Proteins and Metastable Fragments Using Matrix-Assisted Laser Desorption/Ionization, Axial Time-of-Flight Mass Spectrometry, and TPX3CAM

Bispecific Binding Molecules Against Vegf and Ang2

Humanized, Mouse Or Chimeric Anti-CD47 Monoclonal Antibodies

Hallmarks of Alpha and Betacoronavirus Non-Structural Protein 7+8 Complexes

An IgG-Based Bispecific Antibody for Improved Dual Targeting in PSMA-Positive Cancer

The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism

Anti-SIRPα Antibodies

Switzerland

United States

France